Benjamin L. Judson, MD

Associate Professor of Surgery (Otolaryngology); Associate Residency Program Director, Otolaryngology; Medical Director, Ambulatory Clinics, Smilow Cancer Hospital at Yale-New Haven

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Surgery: Otolaryngology Surgery: Head & Neck Cancer Surgery Program

Yale Cancer Center: Head & Neck Cancers Program

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Otolaryngology AB of Otolaryngology (2008)

Clinical Trials

Conditions Study Title
Other Skin A Phase 2, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Pembrolizumab in Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC)
Larynx, Lip, Oral Cavity and Pharynx A Randomized Phase III Study of Pembrolizumab Given Concomitantly With Chemoradiation and as Maintenance Therapy Versus Chemoradiation Alone in Subjects With Locally Advanced Head and Neck Squamous Cell Carcinoma (KEYNOTE-412)
Lip, Oral Cavity and Pharynx, Soft Tissue A Phase II Study of Enzalutamide (NSC# 766085) for Patients With Androgen Receptor Positive Salivary Cancers
Larynx, Lip, Oral Cavity and Pharynx Single-Arm Phase II Trial of Dual Inhibition of EGFR With Afatinib and Cetuximab With Correlative Studies in the Second-Line Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck
Lip, Oral Cavity and Pharynx A Two-arm, Open-label, Randomized Phase II Study of Pembrolizumab (MK-3475) Monotherapy Versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)
Larynx, Lip, Oral Cavity and Pharynx, Ill-Defined Sites A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
Lip, Oral Cavity and Pharynx Window Trial 5-aza in HNSCC, T-tare
Lip, Oral Cavity and Pharynx Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Edit this profile

Contact Info

Benjamin L. Judson, MD
Patient Care Locations
Yale Head & Neck Cancer ProgramSmilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 4th Floor Multispecialty Care Center
New Haven, CT 06511
View on map...
Yale OtolaryngologyYale Physicians Building
800 Howard Avenue, Ste 4th Floor
New Haven, CT 06519
View on map...
Yale Cancer CenterYale New Haven Hospital
20 York Street, Ste East Pavilion
New Haven, CT 06510
View on map...
Mailing Address
Otolaryngology Surgery330 Cedar Street
PO Box 208062
New Haven, CT 06520-8062

Curriculum Vitae

  • MyChart

    Learn more & Signup